Lisata Therapeutics Inc (NASDAQ:LSTA), a clinical-stage company developing therapies for advanced solid tumors, announced that its CEO David J Mazzo will deliver a corporate overview in a pre-recorded, on-demand presentation at the HC Wainwright 27th Annual Global Investment Conference in New York City, being held from September 8 to 10.
The recording of the presentation will be available starting September 5 at 7am Eastern Time.